ProKidney prices upsized $130M offering of 53.7M shares at $2.42 per share

PROKIDNEY CORP.

Total offering of 53,719,009 shares at $2.42/share; net proceeds expected ~$136.7M.
Public offering of 42,744,220 shares; underwriters have 30-day option for 6,411,633 more.
Concurrent direct offering of 11,030,574 shares to certain investors; closings not contingent.
Expected close June 13; proceeds for clinical trials, R&D, pre-commercial activities.
Jefferies, J.P. Morgan, Guggenheim lead underwriting; PJT Partners as co-manager/adviser.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.